brimonidine tartrate

Generic: brimonidine tartrate

Labeler: sandoz inc
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name brimonidine tartrate
Generic Name brimonidine tartrate
Labeler sandoz inc
Dosage Form SOLUTION
Routes
OPHTHALMIC
Active Ingredients

brimonidine tartrate 1.5 mg/mL

Manufacturer
Sandoz Inc

Identifiers & Regulatory

Product NDC 61314-144
Product ID 61314-144_6a98ed35-7065-4099-aefc-6d22e674ef55
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA021764
Listing Expiration 2026-12-31
Marketing Start 2010-10-02

Pharmacologic Class

Classes
adrenergic alpha-agonists [moa] alpha-adrenergic agonist [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 61314144
Hyphenated Format 61314-144

Supplemental Identifiers

RxCUI
861208
UPC
0361314144058
UNII
4S9CL2DY2H

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name brimonidine tartrate (source: ndc)
Generic Name brimonidine tartrate (source: ndc)
Application Number NDA021764 (source: ndc)
Routes
OPHTHALMIC
source: ndc

Resolved Composition

Strengths
  • 1.5 mg/mL
source: ndc
Packaging
  • 1 BOTTLE in 1 CARTON (61314-144-05) / 5 mL in 1 BOTTLE
  • 1 BOTTLE in 1 CARTON (61314-144-10) / 10 mL in 1 BOTTLE
  • 1 BOTTLE in 1 CARTON (61314-144-15) / 15 mL in 1 BOTTLE
source: ndc

Packages (3)

Ingredients (1)

brimonidine tartrate (1.5 mg/mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["OPHTHALMIC"], "spl_id": "6a98ed35-7065-4099-aefc-6d22e674ef55", "openfda": {"upc": ["0361314144058"], "unii": ["4S9CL2DY2H"], "rxcui": ["861208"], "spl_set_id": ["b1e7ebd4-d0d2-40a5-aa11-5f68bc5972bd"], "manufacturer_name": ["Sandoz Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (61314-144-05)  / 5 mL in 1 BOTTLE", "package_ndc": "61314-144-05", "marketing_start_date": "20101002"}, {"sample": false, "description": "1 BOTTLE in 1 CARTON (61314-144-10)  / 10 mL in 1 BOTTLE", "package_ndc": "61314-144-10", "marketing_start_date": "20101002"}, {"sample": false, "description": "1 BOTTLE in 1 CARTON (61314-144-15)  / 15 mL in 1 BOTTLE", "package_ndc": "61314-144-15", "marketing_start_date": "20101002"}], "brand_name": "Brimonidine Tartrate", "product_id": "61314-144_6a98ed35-7065-4099-aefc-6d22e674ef55", "dosage_form": "SOLUTION", "pharm_class": ["Adrenergic alpha-Agonists [MoA]", "alpha-Adrenergic Agonist [EPC]"], "product_ndc": "61314-144", "generic_name": "Brimonidine Tartrate", "labeler_name": "Sandoz Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Brimonidine Tartrate", "active_ingredients": [{"name": "BRIMONIDINE TARTRATE", "strength": "1.5 mg/mL"}], "application_number": "NDA021764", "marketing_category": "NDA", "marketing_start_date": "20101002", "listing_expiration_date": "20261231"}